GVBL exchange filings, corporate actions and results
31 Aug 2026
⚑ Filing
Genomic Valley Biotech Ltd - 539206 - Intimation Of Approval Of Extension Of Time For Holding Annual General Meeting (AGM) Of The Company For The Financial Year Ended On 31St March 2026, Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
14 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹0 Cr (−57.8% YoY), PAT ₹0 Cr (−40.9% YoY)BSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E. 14Th August 2026BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
